Milrinone Lactate Injection 200 mcg — Class II drug recall D-1486-2019
Terminated recall by Pfizer Inc., reported 2019-07-24, distributed in GU, PR. Lack of Assurance of Sterility: Bags have the potential to leak.
| Recall number | D-1486-2019 |
|---|---|
| Product type | Drug |
| Classification | Class II |
| Status | Terminated |
| Voluntary or mandated | Voluntary |
| Recalling firm | Pfizer Inc., New York, NY, United States |
| Recall initiated | 2019-07-09 |
| Classified | 2019-07-12 |
| Reported by FDA | 2019-07-24 |
| Terminated | 2021-10-27 |
| Distributed | GU, PR |
| Quantity | 58,200 bags |
| Reason classes | sterility, packaging |
| UPC / GTIN / UDI-DI | 00304092776028 |
| NDC | 00409-2776-02 |
| Lot numbers | 86-615-KL, 87-701-KL, 90-114-KL |
| Expiration dates | 2020-02-01, 2020-03-01, 2020-06-01 |
Product
Milrinone Lactate Injection 200 mcg (0.2 mg)/mL* in 5% Dextrose Injection 40 mg/200 mL, 200 mL bag, Rx Only, Hospira, Inc., Lake Forest, IL 60045 USA, NDC 0409-2776-02, Barcode (01)00304092776028.
Reason for recall
Lack of Assurance of Sterility: Bags have the potential to leak.
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-1486-2019. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.